A preview of this week's International Patent Forum

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

A preview of this week's International Patent Forum

Managing IP's annual International Patent Forum takes place this Wednesday and Thursday, and includes a keynote from Mr Justice Arnold and panels on the UPC, Brexit, the Internet of Things, second medical use patents, FRAND and much more

waldorf-london-400.jpg

We're delighted to confirm that Mr Justice Arnold will open the Forum, which takes place at the Waldorf Hilton London on March 8 and 9.

Arnold has been a High Court judge since 2008 and the judge in charge of the Patents Court in the UK since 2013. He has written important judgments in many patent cases, as well as in many other areas of IP, and last year sat in his first case in the Court of Appeal.

Recently, he also co-authored a paper on the legal consequences of Brexit through the lens of IP law, which is essential reading for anyone interested in this topic.

Arnold's keynote is scheduled for 9.00 am on March 8 so if you are attending the Forum make sure you arrive early. 

If you are not yet registered, there are still a few places available - details are here, but act fast!

The full programme, including names of speakers, is available here.

Over the two days, we have panels on many topical patent issues including:



  • Brexit, Article 50 and the UPC

  • Patentable subject matter: Alice, the EPO and enforcement

  • Internet of Things: IP, privacy and licensing

  • Litigation strategy: filing strategies, preliminary injunctions and forum shopping

  • Patent enforcement: harmonisation, Brexit and design patents

  • Second medical use claims: pregabalin, Warner-Lambert v Actavis and more (see also our recent roundtable discussion on this topic)

  • FRAND: SEPs in Europe, Huawei v Unwired Planet and dispute resolution

  • The Patent Box: recent changes, IP strategies and thinking outside the (patent) box

  • Trade secrets: the EU Directive, China and the US, the first DTSA cases

  • IP and commercial strategies: IP monetisation, security and emerging markets



Reflecting the international nature of this Forum, we will also have dedicated sessions on developments in:



  • China: specialist courts two years on, parallel proceedings and is China now safe for IP?

  • India: recent improvements and specialist IP courts possibilities

  • Turkey: all you need toknow about the new IP Code



There will be a drinks reception on the evening of March 8, starting at about 5.00 pm to which all attendees and speakers are invited. 

On the evening of March 9 our annual Global Awards Dinner takes place at the Savoy. More information on that, including shortlists for the awards categories, is available here.





more from across site and SHARED ros bottom lb

More from across our site

News of Avanci hiring a senior vice president and the EPO teaming up with a French AI startup were also among the top talking points
Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Gift this article